Life-Science Startups
Life-Science Startups
Regenerative medicine / Stem cells / Signal peptides.
Toyo Bijin Capital · A Letter to Long‑Term Capital
The Group's strategic investment arm is not an independent fund, nor does it raise outside capital — it deploys capital the Group has built up over generations.
The Other Wheel
"Letting the most patient research meet the most enduring capital."
This promise belongs to the Kyoto Life Sciences Institute as much as to Toyo Bijin Capital. The life sciences engine and the strategic investment engine are not two parallel departments but two expressions of one enduring commitment.
Toyo Bijin Capital exists not so the Group can "also do some investing," but so the Group's R&D cycles are no longer dictated by the quarterly rhythm of the markets — patient capital is what makes patient research possible.
Three Convictions
Long‑Termism
Each investment cycle is at least 7-10 years, aligned with the R&D cycle of the Kyoto Institute. We do not chase quarterly returns; we walk alongside a journey of science.
Reciprocity
The technology of portfolio companies can be absorbed and adapted by the Group's product lines — the point where our two engines, capital and research, truly engage.
Scientific Patience
We invest not only in companies but in scientists themselves. We believe that treating researchers with patience is the only reliable source of long‑term return.
Life-Science Startups
Regenerative medicine / Stem cells / Signal peptides.
Women's Health Frontier
Echoing Bijin Privé and the Group's Women's Wellness Initiative.
Sustainable Beauty Materials
Echoing the Group's environmental commitment, driving the industry toward green chemistry.
· Aligned with the Group's R&D strategy.
· Aligned with the Group's sustainability strategy.
· We do not invest in financial-arbitrage projects unrelated to the Group's core mission — however tempting the short-term return.
This boundary is the most fundamental difference between Toyo Bijin Capital and an ordinary financial-type fund.
"A senior scientist once backed by Toyo Bijin Capital,
after years of repair-focused research,
saw the fruits transformed into a core ingredient of the Group's next-generation intimate products."
Industry, Innovation & Infrastructure
Partnerships for the Goals